Estudo randomizado | Drogas protetoras cardíacas parecem ser desnecessárias para a maioria das pacientes com câncer de mama submetidas a tratamento adjuvante.

Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA) Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol – Circulation

Comentários: Heart-protecting drugs likely unnecessary for many breast cancer patients – American College of Cardiology